A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.


Updates from The Motley Fool

Latest updates on XOMA from Fool.com.


Stock Performance

XOMA vs. S&P 500 | 2 Year Performance
View Interactive XOMA Charts
Sponsored by

Key Data Points

Primary metrics and data points about XOMA.
Current Price: $0.47
Prev Close: $0.48
Open: $0.48
Bid: $0.45
Ask: $0.48
Day's Range: $0.46 - $0.50
52wk Range: $0.44 - $2.03
Volume: 651,360
Avg Vol 953,180
Market Cap: $55.55M
P/E (ttm): 24.10
EPS (ttm): $0.02
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about XOMA.
CAPS Rating 3 out of 5
 
334 Outperform
34 Underperform
CAPS All Stars
 
33 Outperform
12 Underperform

How do you think XOMA will perform against the market?



You pick for XOMA is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John Varian, CEO

85% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for XOMA.

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers